Review discusses strategies to mitigate Streptococcus suis transmission and disease, highlighting key molecular mechanisms and control measures.
Streptococcus suis ( S. suis ) is an emerging zoonotic agent that now rivals classical food‐borne pathogens in its global clinical burden of meningitis and septic shock. Recent epidemiological syntheses covering more than 30 countries now list over 1600 laboratory‐confirmed human cases with a pooled case‐fatality of about 12%, climbing beyond 18% in East Asia. The widely cited pooled case‐fatality estimate derives from a PRISMA‐guided systematic review and meta‐analysis that searched PubMed, Scopus, Web of Science, ScienceDirect, and Google Scholar through December 2012 and pooled study‐level event rates using inverse‐variance methods with random‐effects models when heterogeneity was present. We critically synthesize recent molecular, cellular, and translational studies to define how this swine commensal breaches host epithelial and blood–brain barriers (BBBs), subverts innate immunity, and disseminates systemically. Newly identified virulence mechanisms include serine–threonine kinase‐driven claudin‐5 cleavage, vimentin‐dependent transcytosis, quorum‐sensing control of biofilm maturation, and metabolic reprogramming that fuels neutrophil evasion. We integrate multiomics signatures with structural data to map conserved targets such as IdeSui and capsular polysaccharide that underpin next‐generation conjugate and nanoparticle vaccines. Diagnostic advances spanning CRISPR‐based assays and high‐resolution imaging are assessed for their capacity to enable point‐of‐care detection. We also highlight host transcriptomic signatures that can be integrated into microfluidic chips, allowing syndromic discrimination between S. suis and pneumococcal meningitis within 40 min, a critical window for targeted therapy. Finally, we present a prevention framework uniting farm biosecurity, rational antibiotic stewardship, probiotic and bacteriocin interventions, and community education. Collectively, the review delivers an up‐to‐date roadmap for mitigating S. suis transmission and disease, highlights outstanding knowledge gaps in host–pathogen interactions, and outlines translational priorities needed to transform bench discoveries into effective public health countermeasures.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: